Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 3/2020

12.10.2019 | Case Report

Bone metastasis as a recurrence of early papillary adenocarcinoma of the stomach

verfasst von: Nobukazu Agatsuma, Yoshitaka Nishikawa, Takahiro Horimatsu, Yasuki Nakatani, Noriko Juri, Takuji Akamatsu, Takeshi Seta, Sachiko Minamiguchi, Yukitaka Yamashita

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Papillary adenocarcinomas of the stomach are rare and associated with a high rate of lymphovascular invasion and distant metastasis. However, the association between papillary adenocarcinoma and bone metastasis in gastric cancer remains largely unexplored. We report a rare case of bone metastasis as a recurrence of early papillary adenocarcinoma of the stomach after curative surgery. A 75-year-old man with a pedunculated polyp at the pylorus of the stomach was diagnosed with papillary adenocarcinoma after biopsy of the lesion, and the polyp was surgically resected. Pathohistological examination revealed intramucosal cancer without lymphovascular invasion or lymph node metastasis. Eight months after surgery, imaging studies showed osteolysis in the right sacrum, and the lesion was diagnosed as a bone metastasis after biopsy. The patient received palliative chemotherapy and radiotherapy for the bone metastasis, which resulted in relief of his leg pain. Subsequently, he was provided supportive care when his condition deteriorated, and he died 8 months after the diagnosis of bone metastasis. Our case shows that bone metastasis should not be overlooked, even though it is rare in gastric cancer patients. Papillary adenocarcinoma of the stomach should be carefully followed up through imaging examinations, even after curative resection.
Literatur
1.
Zurück zum Zitat Gotoda T, Jung H-Y. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;25(Suppl 1):55–63.CrossRef Gotoda T, Jung H-Y. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;25(Suppl 1):55–63.CrossRef
2.
Zurück zum Zitat Lai JF, Kim S, Kim K, et al. Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol. 2009;16:1896–902.CrossRef Lai JF, Kim S, Kim K, et al. Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol. 2009;16:1896–902.CrossRef
3.
Zurück zum Zitat Youn HG, An JY, Choi MG, et al. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol. 2010;17:448–54.CrossRef Youn HG, An JY, Choi MG, et al. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol. 2010;17:448–54.CrossRef
4.
Zurück zum Zitat Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19:198–205.CrossRef Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19:198–205.CrossRef
5.
Zurück zum Zitat Sun W, Han X, Wu S, et al. Endoscopic resection versus surgical resection for early gastric cancer. Medicine (Baltimore). 2015;94:e1649.CrossRef Sun W, Han X, Wu S, et al. Endoscopic resection versus surgical resection for early gastric cancer. Medicine (Baltimore). 2015;94:e1649.CrossRef
6.
Zurück zum Zitat Choi HJ, Kim SM, An JY, et al. Risk factors and tumor recurrence in pT1N0M0 gastric cancer after surgical treatment. J Gastric Cancer. 2016;16:215–20.CrossRef Choi HJ, Kim SM, An JY, et al. Risk factors and tumor recurrence in pT1N0M0 gastric cancer after surgical treatment. J Gastric Cancer. 2016;16:215–20.CrossRef
7.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRef Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRef
8.
Zurück zum Zitat Yu H, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular early gastric carcinoma. J Cancer. 2017;8:117–23.CrossRef Yu H, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular early gastric carcinoma. J Cancer. 2017;8:117–23.CrossRef
9.
Zurück zum Zitat Fujita T, Gotohda N, Kato Y, et al. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer. 2012;15:179–87.CrossRef Fujita T, Gotohda N, Kato Y, et al. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer. 2012;15:179–87.CrossRef
10.
Zurück zum Zitat Nakashima Y, Yao T, Hirahashi M, et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 2011;59:841–9.CrossRef Nakashima Y, Yao T, Hirahashi M, et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 2011;59:841–9.CrossRef
11.
Zurück zum Zitat Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584–93.CrossRef Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584–93.CrossRef
12.
Zurück zum Zitat Park JM, Song KY, Kim WC, et al. Bone recurrence after curative resection of gastric cancer. Gastric Cancer. 2013;16:362–9.CrossRef Park JM, Song KY, Kim WC, et al. Bone recurrence after curative resection of gastric cancer. Gastric Cancer. 2013;16:362–9.CrossRef
13.
Zurück zum Zitat Kobayashi M, Okabayashi T, Sano T, et al. Metastatic bone cancer as a recurrence of early gastric cancer––characteristics and possible mechanisms. World J Gastroenterol. 2005;11:5587–91.CrossRef Kobayashi M, Okabayashi T, Sano T, et al. Metastatic bone cancer as a recurrence of early gastric cancer––characteristics and possible mechanisms. World J Gastroenterol. 2005;11:5587–91.CrossRef
14.
Zurück zum Zitat Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.CrossRef Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.CrossRef
15.
Zurück zum Zitat Nakamura T, Yao T, Kabashima A, et al. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology. 2005;47:357–67.CrossRef Nakamura T, Yao T, Kabashima A, et al. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology. 2005;47:357–67.CrossRef
16.
Zurück zum Zitat Kelly PJ, Peterson LFA, Pease DC, Zamboni L. Circulation of Bone. In: Abramson DI, editor. Blood vessels and lymphatics. 1st ed. New York: Academic Press; 1962. p. 531–556. Kelly PJ, Peterson LFA, Pease DC, Zamboni L. Circulation of Bone. In: Abramson DI, editor. Blood vessels and lymphatics. 1st ed. New York: Academic Press; 1962. p. 531–556.
17.
Zurück zum Zitat Takeuchi H, Kitagawa Y. Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci. 2010;17:577–82.CrossRef Takeuchi H, Kitagawa Y. Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci. 2010;17:577–82.CrossRef
18.
Zurück zum Zitat Shimazu K, Fukuda K, Yoshida T, et al. High circulating tumor cell concentrations in a specific subtype of gastric cancer with diffuse bone metastasis at diagnosis. World J Gastroenterol. 2016;22:6083–8.CrossRef Shimazu K, Fukuda K, Yoshida T, et al. High circulating tumor cell concentrations in a specific subtype of gastric cancer with diffuse bone metastasis at diagnosis. World J Gastroenterol. 2016;22:6083–8.CrossRef
19.
Zurück zum Zitat De Felice F, Piccioli A, Musio D, et al. The role of radiation therapy in bone metastases management. Oncotarget. 2017;8:25691–9.CrossRef De Felice F, Piccioli A, Musio D, et al. The role of radiation therapy in bone metastases management. Oncotarget. 2017;8:25691–9.CrossRef
20.
Zurück zum Zitat Body J-J. Denosumab for the management of bone disease in patients with solid tumors. Expert Rev Anticancer Ther. 2012;12:307–22.CrossRef Body J-J. Denosumab for the management of bone disease in patients with solid tumors. Expert Rev Anticancer Ther. 2012;12:307–22.CrossRef
21.
Zurück zum Zitat Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PLoS ONE. 2013;8:e74402.CrossRef Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PLoS ONE. 2013;8:e74402.CrossRef
Metadaten
Titel
Bone metastasis as a recurrence of early papillary adenocarcinoma of the stomach
verfasst von
Nobukazu Agatsuma
Yoshitaka Nishikawa
Takahiro Horimatsu
Yasuki Nakatani
Noriko Juri
Takuji Akamatsu
Takeshi Seta
Sachiko Minamiguchi
Yukitaka Yamashita
Publikationsdatum
12.10.2019
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 3/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01050-1

Weitere Artikel der Ausgabe 3/2020

Clinical Journal of Gastroenterology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.